Meeting Register Page

Transforming the Study of Human Disease with Imaging Mass Cytometry (IMC™) driven by CyTOF®
In this era of personalized medicine, high-dimensional single-cell analysis is becoming critical to the study of human disease. Traditional approaches, like flow cytometry and RNAseq are typically performed in single-cell suspensions thus missing the spatial information and the tissue context. Tissue-imaging techniques like Immunofluorescence (IF) suffer from background fluorescence and spectral overlap, thus limiting the number of biomarkers that can be measured.
The advent of Imaging Mass Cytometry™ (IMC™) has enabled highly multiplexed immunohistochemistry of frozen and formalin-fixed, paraffin-embedded (FFPE) tissues using proven CyTOF technology. The technology helped uncover the central role of the immune system in a large variety of diseases including:
-Cancer
-Autoimmune diseases
-Chronic inflammatory diseases
-Neurodegenerative diseases
In this seminar, we will describe the principles of IMC™ and highlight groundbreaking research made possible with this technology.

Sep 17, 2020 03:00 PM in Pacific Time (US and Canada)

Loading
* Required information